Clinical-pathological characteristics of the breast cancers are reported in Table 2; ductal cancer accounts for 74% cases; two out of three breast cancers were diagnosed at stage I or II; more than 60% cancers were hormonal receptors, 14% were Erbb2 receptors + and only 9% were triple negative breast cancers. This evidence concerns the gene NR4A1 and triple-negative breast carcinoma.